Translational IND enabling studies to develop an innovative drug candidate, TOP-V122 for the treatment and prevention of colorectal cancer.

• Unité de recherche: INNOSUISSE
• Numéro de projet: 50865.1 IP-LS
• Titre du projet anglais: Translational IND enabling studies to develop an innovative drug candidate, TOP-V122 for the treatment and prevention of colorectal cancer.

Description succincte (Allemand)

Translational IND enabling studies to develop an innovative drug candidate, TOP-V122 for the treatment and prevention of colorectal cancer.

Description succincte (Anglais)

Translational IND enabling studies to develop an innovative drug candidate, TOP-V122 for the treatment and prevention of colorectal cancer.

Résumé des résultats (Abstract) (Allemand)

Colorectal cancer (CRC) is the second leading cause of cancer death and the third most prevalent cancer worldwide. Survival rate at a later diagnosis is 13.5%. With our approach, based on a unique mode of action drug that restore cGMP levels, we aim to treat CRC and to increase the survival rate.